SpectralMD
Clinical trials sponsored by SpectralMD, explained in plain language.
Now part of
Spectral AI, Inc.
MDAI
NASDAQ
A medical technology company using AI for wound assessment.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI learns to see burns on hands, head, and feet Results expected Apr 2027 (estimated)